MDWerks, Inc. · OTC:MDWK

MDWerks — Investor Presentation (July 2026)

26 slides from MDWerks's investor presentation, July 2026

  1. Slide 1: MDWerks, Inc. Company Presentation July 2026

    Investment Highlights ~$400M IP Valuation MDWerks, Inc. 6-12 Mo. Payback Per System Molecular Targeting Technology Platform 3 Contracts Signed Spirits · Wood Products · Industrial Processing · Future Markets $71M+ Revenue Target by 2031 Company Presentation ● July 2026 OTCQB: MDWK OTCQB: MDWK mdwerk

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements This presentation contains "forward-looking statements." Forward-looking statements also may be included in other publicly available documents issued by MDWK and in oral statements made by our officers and representatives from time to time. These forward-looking statements

  3. Slide 3: Who We Are — Snapshot of MDWerks, Inc.

    Who We Are — Snapshot of MDWerks, Inc. Technology company pioneering innovative energy wave solutions for a broad MDWerks: Innovative Energy Wave 1 spectrum of industries, backed by the nation's leading energy wave experts. Technology Solutions Headquarters Green Cove Springs, FL Groundbreaking pate

  4. Slide 4: The MDWerks Technology Platform

    The MDWerks Technology Platform What Is Molecular Targeting? Why One Platform Spans Many The Platform Thesis MDWerks applies precisely tuned radio Markets MDWerks is not a single-product company. frequency and microwave energy to The underlying mechanism — selective It is a molecular targeting techn

  5. Slide 5: Appraisal of Intellectual Property — Intrinsic Value ~$400M

    Appraisal of Intellectual Property — Intrinsic Value MDWerks' intellectual property portfolio has been independently valued by a Independent IP Valuation leading financial advisory firm at approximately $400 million (as of May 31, ~$400M 2024), underscoring the substantial market potential of our pa

  6. Slide 6: Intellectual Property & Competitive Moat

    Intellectual Property & Competitive Moat A multi-layer competitive advantage that strengthens with every commercial deployment Patent Estate Proprietary Manufacturing Know-How Commercial Operating Experience Issued US patents cover the formulation (the Years of system design, fabrication, and The Tw

  7. Slide 7: Intellectual Property in the Spirits Industry

    Intellectual Property in the Spirits Industry Why Patent-Protected Aging Technology Is the Most Defensible Moat in Spirits Industry IP Landscape MDWerks IP Advantages Commercial IP Value ▸ The spirits industry has historically been ▸ Patented RF/microwave molecular targeting ▸ $400M+ independent val

  8. Slide 8: The Problem: Industrial Inefficiency, Rising Costs and Environmental Strain

    The Problem: Industrial Inefficiency, Rising Costs and Environmental Strain Traditional industrial processes face significant challenges in efficiency, cost, and environmental sustainability — creating barriers to innovation and hindering industries from meeting modern demands. 01 02 03 Inefficient

  9. Slide 9: The Solution: Our Transformative Energy Wave Technology Platform

    The Solution: Our Transformative Energy Wave Technology Platform Our patented energy wave technology introduces specific molecular targeting — applied at precise and multiple locations — delivering improved manufacturing and financial efficiency, higher quality, and reduced processing time versus co

  10. Slide 10: Why Customers Adopt MDWerks

    Why Customers Adopt MDWerks A side-by-side comparison of traditional manufacturing economics versus the MDWerks platform MANUFACTURING DIMENSION TRADITIONAL PROCESS MDWERKS PLATFORM Production Cycle Time Years (spirits) / Hours (wood drying) with conventional Days (spirits rapid aging) / Faster thro

  11. Slide 11: Two Trees Distillery — In-House Large Capacity Spirits Rapid Aging System

    Two Trees Distillery — In-House Large Capacity Spirits Rapid Aging System Proprietary Technology — Built by RFS Specialties 5,600 Utilizing MDWerks patented radio frequency and microwave energy technology to achieve molecular-level rapid aging — producing award-winning craft spirits at 5,600 gallons

  12. Slide 12: Spirits Rapid Aging System — Spirits Licensing Business Model

    Spirits Rapid Aging System — Spirits Licensing Business Model February 2025 – Signed contracts to build and deploy new Spirits Rapid Aging Systems ("SRAS") at third-party customer facilities: Large U.S. Distillery Wholesaler and Broker of Bulk Spirits ◦ First unit on track for completion in Q3 2026

  13. Slide 13: SRAS — Licensing Model & Financial Metrics

    SRAS — Licensing Model & Financial Metrics 3 $200K $1M 6-12 Mo. Systems Avg. Monthly Revenue / System Build Cost / Machine Expected Payback Period Contracts in Place $50K/month contractual minimum Total per SRAS unit Estimated per system Deployment begins Q3 2026 Per System ROI Analysis Cumulative R

  14. Slide 14: RF Technology Applications — Lumber & Wood Products Sector

    RF Technology Applications — Lumber & Wood Products Sector RF Technology Applications Commercial Deployment: Scheduled to complete installation of first MSDS unit to one of the leading sawmills and lumber producers in the United States, August 2026. Molecular Sawdust Drying 1 RF energy precisely rem

  15. Slide 15: Molecular Sawdust Drying System — Scalability, Flexibility, Productivity

    Molecular Sawdust Drying System — Scalability, Flexibility, Productivity Wood pellets have become a popular choice as a green and lower-cost alternative to fossil fuels like coal. Our molecular sawdust drying system offers scalable, flexible solutions for Versus Traditional Methods: any tonnage of s

  16. Slide 16: A Scalable, Recurring Revenue Model

    A Scalable, Recurring Revenue Model We deliver our advanced industrial solutions through a service-based model that leverages our patented energy wave technology. By offering our technical equipment through a flexible technology licensing structure, we enable customers to access transformative techn

  17. Slide 17: Why the Platform Grows Stronger With Every Deployment

    Why the Platform Grows Stronger With Every Deployment Each commercial installation generates recurring revenue and simultaneously compounds the platform's competitive advantage A Self-Reinforcing Platform Operating Data Deployments capture process metrics, quality benchmarks, and efficiency data ret

  18. Slide 18: Addressable Markets and Market Drivers

    Addressable Markets and Market Drivers The markets we serve are interconnected by a shared need for efficiency, sustainability, and scalability. Our technology not only addresses existing market demands but also creates Future Markets opportunities for innovation in emerging sectors. Beverage Indust

  19. Slide 19: Platform Expansion Strategy

    Platform Expansion Strategy A disciplined commercialization roadmap — from proven markets to adjacent and long-term industrial opportunities CURRENT COMMERCIAL MARKETS NEAR-TERM EXPANSION LONG-TERM OPPORTUNITIES Spirits — Rapid Aging Food & Beverage Processing Agriculture 3 signed licensing contract

  20. Slide 20: Multi-Year Projections — Scalability & Profitability of Business Model

    Multi-Year Projections — Scalability & Profitability of Business Model $75M $71M Areas of Growth: $65M SRAS System Licensing $60M Revenue accelerates as licenses begin coming $55M online in Q3 2026. Establishes the foundation of our recurring revenue model. $45M $45M $39M $35M $32M $32M MSD (Molecul

  21. Slide 21: MDWerks Path to Profitability

    MDWerks Path to Profitability A clear, stage-gated revenue model — from first licensing contracts to scalable, self-sustaining profitability PHASE 1 PHASE 2 PHASE 3 Foundation Scaling Acceleration (Q3 2026 – Q2 2027) (Q3 2027 – Q4 2028) (FY 2029 – FY 2031) ▸ 3 signed contracts deploy — SRAS-001, 002

  22. Slide 22: Break-Even Timeline & $500K Investment Viability

    Break-Even Timeline & $500K Investment Viability Break-Even Analysis — Cumulative Cash Flow Is $500K Viable? $18,000K $16,000K YES — Financially Viable $14,000K $12,000K Capital Unlock: $500K funds SRAS-001 — the first external unit (3 mo. to deployment) $10,000K $8,000K Revenue Impact: SRAS-001 gen

  23. Slide 23: Use of Proceeds — Deploying Investor Capital to Drive Revenue

    Use of Proceeds — Deploying Investor Capital to Drive Revenue Every dollar raised is directly tied to deployments that generate predictable, recurring licensing revenue. Deployment Capital Needed % of Round Annual Recurring Revenue Timeline SRAS-001 (Large U.S. Distillery) $500,000 20% $2.4M/yr recu

  24. Slide 24: Investment Conclusions

    Investment Conclusions 1 Remarkably fast payback on investment — estimated 6–12 months per SRAS system 2 Multiple contracts in hand with signed agreements and additional pending discussions 3 Revenue sources from multiple industries: spirits, lumber, adhesives, and future markets 4 Attractive, scala

  25. Slide 25: The MDWerks Platform Thesis

    MDWerks, Inc. OTCQB: MDWK The MDWerks Platform Thesis MDWerks is commercializing a patented molecular targeting technology platform with applications across multiple industrial sectors. Today, commercialization is underway in spirits and wood products through signed customer contracts and initial de

  26. Slide 26: Forward-Looking Statements

    Forward-Looking Statements This presentation contains "forward-looking statements." Forward-looking statements also may be included in other publicly available documents issued by MDWK and in oral statements made by our officers and representatives from time to time. These forward-looking statements

MDWerks — Investor Presentation (July 2026) on 6ix